Key factors that mediate vascular smooth muscle cell proliferation and migration are platelet-derived growth factor (PDGF) and thrombospondin 1 (TSP1). We now report that PDGF BB bound tightly and specifically to TSP1, that this interaction was markedly dependent on the disulphide bond arrangement in TSP1, and that binding of PDGF BB to TSP1 did not preclude PDGF BB from binding to its receptor on rat aortic vascular smooth-muscle cells. At physiological ionic strength and pH, PDGF BB bound to Ca# + -depleted TSP1 with a dissociation constant of 11p2 nM and to Ca# + -replete TSP1 with a dissociation constant of 32p5 nM. Binding was specific, as both soluble TSP1 and unlabelled PDGF BB competed for binding of iodinated PDGF BB to immobilized TSP1, whereas other platelet α-granule proteins did not compete. The tertiary structure of TSP1 is regulated by intramolecular disulphide interchange ; we
INTRODUCTION
Platelet-derived growth factor (PDGF) was discovered as a major mitogenic factor in serum, absent from plasma, and was subsequently shown to be secreted from platelet α-granules [1] [2] [3] [4] . PDGF is produced by many cells, including arterial endothelial and vascular smooth-muscle cells (SMCs), monocyte\macro-phages, fibroblasts, and a variety of transformed cells. PDGF is a potent mitogen for fibroblasts, glial cells, arterial SMCs and some epithelial and endothelial cells, and is also chemotactic for fibroblasts, SMCs, neutrophils and mononuclear cells. PDGF is a dimer of two possible polypeptide chains, A and B, and interacts with two distinct PDGF receptors on cell surfaces. PDGF has been implicated in a variety of normal and pathological processes, including wound healing, nerve regeneration, glial cell proliferation and differentiation, and neoplastic transformation and tumour pathogenesis. In particular, PDGF has been strongly implicated in atherogenesis [5] .
Thrombospondins are a family of multidomain glycoproteins from platelets and most normal and transformed cells. Thrombospondin 1 (TSP1), the platelet TSP, is the best studied and most pervasive and has been shown to play an important role in cell-cell and cell-matrix interactions [6] [7] [8] . TSP1 is a multidomain Ca# + -sensitive disulphide-bonded trimer with a subunit molecular mass of 150 kDa. Most normal and transformed cells in culture, including fibroblasts [9] , endothelial cells [10] and SMCs [11] synthesize and secrete TSP1. TSP1 binds to at least four different cell-surface receptors via separate binding motifs [12] [13] [14] [15] . TSP1 is a transient component of extracellular matrices in i o during embryogenesis [16, 17] , wound repair [18] and in neoplastic tissues [19] , and has been proposed to function in tissue development and remodelling, and in neoplasia.
PDGF and TSP1 activities are closely linked in the pathogenesis of atherosclerosis. The atherosclerotic lesion results from Abbreviations used : FGF, fibroblast growth factor ; PDGF, platelet-derived growth factor ; PDI, human placenta protein disulphide isomerase ; SMC, smooth-muscle cell ; TSP1, human platelet thrombospondin 1. 1 To whom correspondence should be addressed.
found that catalysis of disulphide interchange in TSP1 by protein disulphide isomerase ablated the binding of PDGF BB . The interaction of PDGF BB with TSP1 was weakened by increasing salt concentration and essentially ablated at 0n65 ionic strength ; it was inhibited by heparin with a half-maximal effect at 20 i.u.\ml, implying that the binding was mediated largely by ionic interactions. An anti TSP1 monoclonal antibody decreased the binding of iodinated PDGF BB to PDGF receptor on rat aortic vascular smooth-muscle cells by 37p2 %, whereas platelet TSP1 non-competitively inhibited binding of iodinated PDGF BB . Uncomplexed PDGF BB bound to PDGF receptor with an affinity 5p2 times that of PDGF BB -TSP1 complexes. These results suggest that TSP1 might assist in the targeting of PDGF to its receptor on vascular smooth-muscle cells.
various forms of injury to the endothelium and smooth muscle of the artery wall. A hallmark of the disease is uncontrolled migration and proliferation of SMCs, which results in thickening of the vascular wall and contributes to the eventual occlusion of the artery. PDGF is made by most cells in atherosclerotic lesions and is generally considered to be an important factor responsible for the excessive migration and proliferation of SMCs [5] . TSP1 is found in large amounts in atherosclerotic lesions [20] and derives mostly from activated SMCs [21] . TSP1 is expressed as an immediate-early response to PDGF stimulation of cultured SMCs [22] . These findings imply that PDGF and TSP1 colocalize extracellularly in atherosclerotic lesions. Studies with monoclonal anti-TSP1 antibodies to neutralize endogenously produced TSP1 have shown that TSP1 is a requirement for PDGF-mediated proliferation [23] and migration [24] of SMC. Majack et al. [23] reported that five monoclonal antibodies against TSP1 specifically inhibited SMC growth in serum, and presented evidence that cell-surface-associated TSP1 is functionally essential for the proliferation of vascular SMCs. Yabkowitz et al. [24] showed that a monoclonal anti-TSP1 antibody negated PDGF-mediated migration of vascular SMCs, and proposed that TSP1 functions as an autocrine motility factor to modulate SMC migration. We now report that PDGF BB binds tightly and specifically to TSP1. Our results suggest that the interaction of TSP1 with PDGF BB might play a role in the targeting of PDGF BB to PDGF receptor on vascular SMCs.
EXPERIMENTAL Proteins
TSP1 was purified from human platelet concentrations as described previously [25] , with the following modifications. Throm-bin used to activate platelets was inactivated with a 4-fold molar excess of -Phe-Pro-Arg-chloromethane, and leupeptin to 10 µM was added to the platelet releasate. Heparin-Sepharose was eluted stepwise with 0n25 M NaCl before elution of the TSP1 with 0n55 M NaCl. Buffers containing 0n1 mM CaCl # were used throughout the chromatographic purification of TSP1. On some occasions, buffers containing 2 mM CaCl # were used. TSP1 was stripped of transforming growth factor β as described by MurphyUllrich et al. [26] . TSP1 concentration was determined with a value of 10n9 for A" % "cm,#)! and a molecular mass of 450 kDa. Human platelet factor 4 and β-thromboglobulin were purified from human platelet concentrates along with TSP1. Platelet factor 4 was eluted from the heparin-Sepharose column with 2 M NaCl, whereas β-thromboglobulin eluted after TSP1 on the Bio-Gel A0n5m (Bio-Rad Laboratories, Hercules CA, U.S.A.) gel-filtration column. Fibrinogen [27] and α # -macroglobulin [28] were purified from human plasma. Protein disulphide isomerase (PDI) was purified from human placenta as described previously [29] . Proteins were homogeneous as judged by SDS\PAGE. Human recombinant PDGF AA (short form) and PDGF BB homodimers and transforming growth factor β were purchased from Genzyme Diagnostics (Cambridge, MA, U.S.A.). Human recombinant "#&I-PDGF BB homodimer (1210 kBq\mg) was from Du Pont (Sydney, Australia). The monoclonal antibodies used herein were purified from mouse ascites fluid by affinity chromatography on Protein G-Sepharose (Pharmacia, Uppsala, Sweden) in accordance with the manufacturer's instruction. Protein Aagarose beads and GSH were from Sigma-Aldrich, NSW, Australia. All proteins were divided into aliquots and stored at k80 mC until use.
Binding of 125 I-PDGF BB to TSP1
TSP1 [100 µl of 10 µg\ml in 20 mM Hepes (pH 7n4)\0n14 M NaCl\2 mM EDTA\0n02 % NaN $ ] was adsorbed to NuncImmuno BreakApart polystyrene wells (Nunc InterMed, Roskilde, Denmark) overnight at 4 mC in a humid environment. The wells were washed once with PBS containing 0n05 % Tween-20, non-specific binding sites were blocked by adding 200 µl of 2% (w\v) BSA in PBS and incubating for 90 min at 37 mC, and then washed three times with binding buffer [20 mM Hepes (pH 7n4)\0n134 M NaCl\2 mM CaCl # or 2 mM EDTA\0n05 % Tween -20] . "#&I-PDGF BB in the presence or absence of various competing proteins, heparin or NaCl was added to wells to a total volume of 100 µl in binding buffer and incubated for 30 min at room temperature on an orbital shaker. This incubation time was determined to be sufficient for the binding interactions to reach equilibrium. Wells were washed three times with binding buffer, separated and counted for radioactivity with a Packard Crystal II γ-radiation counter. Non-specific binding of "#&I-PDGF BB to control wells not coated with TSP1 but blocked with 2 % (w\v) BSA in PBS represented no more than 20 % of the total binding in all experiments.
Effect of PDI-catalysed disulphide interchange in TSP1 on binding of 125 
I-PDGF BB
TSP1 was adsorbed to Nunc-Immuno BreakApart polystyrene wells as described above and incubated with either 20 mM Hepes (pH 7n4)\0n134 M NaCl alone, buffer containing GSH, buffer containing PDI, or buffer containing GSH and PDI for 60 min at 37 mC. The GSH and PDI concentrations were 0n7 mM and 180 nM respectively. The buffer contained either 2 mM EDTA or 2 mM Ca# + . Binding of "#&I-PDGF BB to the treated TSP1 was measured as described above.
Calculation of the dissociation constant for the interaction of PDGF 88 with immobilized TSP1
Competition for the binding of "#&I-PDGF BB to immobilized TSP1 by soluble PDGF BB was performed to calculate the dissociation constant for the interaction of PDGF BB with TSP1. The dissociation constants for the interaction of "#&I-PDGF BB (K H ) or PDGF BB (K C ) with plastic-adsorbed TSP1 are described by : 
. This approach and a similar derivation have been described by Olson et al. [30] . Eqn. (2) is a quadratic in [HT] :
The characterization of the binding system is in two parts. First, the affinity of "#&I-PDGF BB for immobilized TSP1, K H , is estimated from experiments that measure the binding of a range of "#&I-PDGF BB concentrations to a fixed concentration of immobilized TSP1 (see Figure 1a) . Secondly, the affinity of PDGF BB for immobilized TSP1, K C , is estimated from experiments that measure the binding of a fixed concentration of "#&I-PDGF BB to immobilized TSP1 as a function of PDGF BB concentration (see Figure 1b ). Data were fitted to eqns. (1) and (2) by non-linear least-squares regression (Scientist software ; Micromath, Salt Lake City, UT, U.S.A.).
Calculation of the dissociation constant for the interaction of 125 I-PDGF BB with soluble TSP1
To calculate the affinity of "#&I-PDGF BB for soluble TSP1 we used a competitive binding assay that has been described previously [30, 31] . The dissociation constant for the binding of "#&I-PDGF BB to TSP1 is estimated from the ability of soluble TSP1 to compete for binding of "#&I-PDGF BB to plastic-adsorbed TSP1. The dissociation constants for the interaction of "#&I-PDGF BB with plastic-adsorbed TSP1 (K H ) and soluble TSP1 (K S ) are : 
The affinity of "#&I-PDGF BB for soluble TSP1 is estimated from experiments that measure the binding of a fixed concentration of "#&I-PDGF
BB
to immobilized TSP1 as a function of soluble TSP1
Scheme 1 Model for the non-competitive inhibition of binding of PDGF BB to its receptor on SMC by TSP1
PDGF interacts with TSP1 with a dissociation constant K H , and with PDGF receptor on SMCs (PDGFR) with a dissociation constant K R . The model states that both PDGF and PDGF.TSP interact with PDGFR, but the binding of PDGF.TSP is weakened by a factor α. Because of the linked equilibria of this model, TSP must also interact with PDGF.PDGFR with a dissociation constant α.K H .
concentration (see Figure 2) . Importantly, the estimate of the affinity of "#&I-PDGF BB for soluble TSP1 is independent of the mechanism of binding attributed to the interaction of "#&I-PDGF BB with immobilized TSP1 [31] . Data were fitted to eqns. (3) and (4) by non-linear least-squares regression.
Binding of 125 I-PDGF BB to PDGF receptor on rat aortic SMCs
Aortic SMCs from adult Wistar rats were a gift from Dr. Peter Little (Baker Medical Research Institute, Melbourne, Australia) [32] . Binding of "#&I-PDGF BB to cultured rat aortic SMCs was measured as described by Bowen-Pope and Ross [33] . Nonspecific binding was determined by using 0.6 nM or 20 ng\ml unlabelled PDGF BB , approx. 40 times the dissociation constant, and subtracted from the total binding. Non-specific binding represented no more than 15 % of the total binding in all experiments. The effect of unlabelled PDGF BB , TSP1, murine anti-TSP1 monoclonal antibody HB8432 [9] and α # -macroglobulin on the binding of "#&I-PDGF BB to PDGF receptor was determined. HB8432 monoclonal antibody and a control monoclonal antibody generated against bovine liver PDI were used at a final concentration of 100 µg\ml.
Analysis of the non-competitive inhibition of binding of PDGF BB to rat aortic SMCs by TSP1
The effect of TSP1 on binding of labelled PDGF BB to rat aortic SMCs has been fitted to the model described in Scheme 1. In this model, "#&I-PDGF BB (H) interacts with TSP1 (T) with dissociation constant K H , and with PDGF receptor on SMCs (R) with a dissociation constant K R . The model states that both H and HT interact with R, but the binding of HT is weakened by a factor α. Because of the linked equilibria of this model, T must also interact with HR with a dissociation constant αK H . This model is described by eqn. (5) :
where :
Because K R and [R] ! are of similar magnitude (low picomolar) under the conditions of our experiments, an explicit relationship in terms of the known total concentrations of H and T and the parameters K H , K R , [R] ! and α cannot be derived. In other words, the usual assumption that the total concentration of "#&I-PDGF BB will be a good approximation of the free concentration of "#&I-PDGF BB is not valid in our binding system. Therefore eqn. (5) was fitted to the data by numerical integration with a leastsquares minimization procedure (Scientist software ; Micromath). the interaction of "#&I-PDGF BB with soluble TSP1. The application of this competitive binding technique and the method of analysis have been described for a variety of binding systems [30, 31, 34, 35] . The binding system is in two parts. First the interaction of "#&I-PDGF BB with immobilized TSP1 was measured.
RESULTS

Interaction of PDGF BB with TSP1
Binding was measured in pH 7n4 buffer at physiological ionic strength. The binding interactions in this system were reversible (see below) and reached equilibrium in 30 min (results not shown). The results are shown in Figure 1(a) . The binding was characterized by a dissociation constant and maximal number of binding sites of 0n90p0n19 nM and 0n37p0n06 nM respectively (meanspS.D.). To ensure that the binding of radiolabelled PDGF BB to TSP1 was not an artifact due to iodination, competition for binding of "#&I-PDGF BB to immobilized TSP1 by soluble PDGF BB was measured (Figure 1b) . The best fit of the data to eqn. (2) gave a dissociation constant for binding of PDGF BB to immobilized TSP1 of 20p6 nM (meanpS.D.) [30] . Therefore iodinated PDGF BB bound to immobilized TSP1 with an approx. 20-fold tighter affinity than did unlabelled PDGF. The reason for this difference is unknown. When two standard deviations are applied, the dissociation constants are 0n9p0n4 nM for "#&I-PDGF BB and 20p12 nM for PDGF BB . Therefore the dissociation constants are almost within statistical error. The greatest source of experimental error is probably the specific radioactivity of the iodinated PDGF BB and the concentration of the stock unlabelled PDGF BB , which are supplied and characterized by different manufacturers. Considering these factors, the discrepancy in affinities was not considered significant in the context of the studies and was not pursued further. Secondly, the dissociation constant for binding of "#&I-PDGF BB to soluble TSP1 was estimated from the ability of soluble TSP1 to compete for binding of "#&I-PDGF BB to plastic-adsorbed TSP1. An important property of this binding system is that the equilibrium constant measured for the solution-phase interaction is independent of the mechanism ascribed to the binding of the ligand to the immobilized acceptor [34, 35] . These results are shown in Figure 2 . The binding was measured for Ca# + -depleted or -replete TSP1 ; the results are listed in Table 1 . Ca# + -depleted TSP1 bound "#&I-PDGF BB with a dissociation constant of 11p2 nM, whereas Ca# + -replete TSP1 bound "#&I-PDGF BB with a dissociation constant of 32p5 nM. TSP1 was further purified (' stripped ') by gel filtration in Tris buffer, pH approx. 10, to dissociate any contaminating transforming growth factor β [26] . Ca# + -depleted or -replete ' stripped ' TSP1 bound "#&I-PDGF BB with an equivalent dissociation constant of 7 nM, which is comparable with the affinity of "#&I-PDGF BB for untreated TSP1. The alkaline pH used to strip TSP1 of transforming growth factor β probably resulted in some unfolding of the TSP1 protein, which might account for the small perturbation in affinity of the treated TSP1 for PDGF BB . We have shown that transforming growth factor β did not displace PDGF BB from TSP1 (see below), so PDGF BB might be expected to bind both untreated and ' stripped ' TSP1 with equivalent affinity.
From this analysis it is apparent that PDGF BB binds to plasticadsorbed TSP1 with approx. 10-60 times greater affinity than it does to soluble TSP1. One explanation for this finding is that the binding epitope on TSP1 for PDGF BB might be partly cryptic, and that denaturation of TSP1 on binding to plastic facilitates exposure of this epitope. This hypothesis has some support from the finding that change in TSP1 structure by intramolecular disulphide interchange also perturbs PDGF BB binding (see below). However, this explanation must be treated with caution. The number of PDGF-binding sites on TSP1 cannot be determined from the competitive binding experiments shown in Figures 1 and 2 . We have assumed that 1 mol of PDGF BB binds to 1 mol of TSP1, which might be an underestimate considering the homotrimeric structure of TSP1.
Specificity of the PDGF BB -TSP1 interaction
To test the specificity of the PDGF BB -TSP1 interaction, the effects of plasma proteins and other platelet α-granule proteins on binding of "#&I-PDGF BB to immobilized Ca# + -depleted TSP1 were measured. BSA, fibrinogen, β-thromboglobulin and platelet factor 4, and at 100 nM final concentration, did not significantly perturb the "#&I-PDGF BB -TSP1 interaction (results not shown). In contrast, soluble TSP1 at 100 nM decreased the binding of "#&I-PDGF BB to immobilized TSP1 to 9 % of control ( Figure 2) . α # -Macroglobulin is known to interact with PDGF BB with a dissociation constant of 100 nM [36] . In accordance with this observation, we found that 100 nM α # -macroglobulin decreased the binding of "#&I-PDGF BB to immobilized TSP1 by 50 %, which indicated a dissociation constant of approx. 100 nM (results not shown). Methylamine-activated α # -macroglobulin competed similarly to unactivated α # -macroglobulin (results not shown). PDGF AA and transforming growth factor β at 40 nM concentrations had no effect on binding of "#&I-PDGF BB to immobilized TSP1 (results not shown). In contrast, soluble PDGF BB at 40 nM concentration decreased the binding of "#&I-PDGF BB to immobilized TSP1 to 48 % of control (Figure 1b) .
Binding of "#&I-PDGF BB to immobilized Ca# + -depleted TSP1 was inhibited by heparin with a half-maximal effect at 20 i.u.\ml (Figure 3a) . This binding was also weakened by increasing ionic strength and was essentially ablated at 0n65 ionic strength ( Figure  3b ). This implies that the interaction had a large ionic component.
It was expected that PDGF might remain associated with platelet TSP1 during its purification. However, no significant PDGF contamination was observed in any of our TSP1 preparations. Bowen-Pope and Ross [37] described a sensitive receptor-binding assay for PDGF based on competition for binding of radiolabelled PDGF to cultured mesenchymal cells by unlabelled PDGF. Using this assay we estimated that our TSP1 preparations were contaminated with less than 0n01 ng of PDGF per µg of TSP1 (results not shown). Western blotting of the TSP1 preparations with a polyclonal anti-PDGF BB antibody was also negative. These results imply that the majority of PDGF had dissociated and separated from platelet TSP1 during its purification.
Effect of PDI-catalysed disulphide interchange in TSP1 on binding of PDGF BB
The tertiary structure of TSP1 is regulated by intramolecular disulphide isomerization [38] , which can be catalysed by PDI and GSH [29] . GSH is a cofactor for PDI. We tested whether PDGF binding was influenced by disulphide-dependent conformational changes in TSP1. Binding of "#&I-PDGF BB to Ca# + -depleted TSP1 was enhanced after incubation of either Ca# + -depleted or Ca# + -replete TSP1 with GSH alone (Figure 4) . In contrast, binding was inhibited or ablated completely by incubation of either Ca# + -depleted or Ca# + -replete TSP1 with either PDI, or GSH and PDI (Figure 4) .
Binding of PDGF BB to its receptor on rat SMCs
Binding of PDGF BB to PDGF receptor on cultured rat aortic SMCs was measured as described by Bowen-Pope and Ross [37] . Interaction of "#&I-PDGF BB with rat aortic SMCs is shown in Figure 5 (a). To facilitate modelling of the data (see below), bound compared with total "#&I-PDGF The data in the absence of TSP1 were fitted to a single rectangular hyperbola by non-linear least-squares regression. The best fit gave a dissociation constant for interaction of PDGF BB with its receptor on rat SMCs, K R , of 11p1 pM and a total number of receptor-binding sites, [R] ! , of 7p2 pM, which corresponds to a receptor number of 88 fmol per 10' cells. These values are the same as those reported by Bowen-Pope and Ross [33, 37] . Unlabelled PDGF BB was also used to compete with radiolabelled PDGF BB for binding to rat aortic SMC (results not shown). Analysis of this competition isotherm gave K R l 9p 3 pM and [R] ! l 7p1 pM, which are the same as the values calculated from the data of Figure 5 (a).
Effect of anti-TSP1 monoclonal antibody and TSP1 on binding of 125 I-PDGF BB to its receptor on rat SMCs
The anti-TSP1 monoclonal antibody HB8432 partly inhibited the binding of "#&I-PDGF BB to its receptor on rat aortic SMCs (results not shown). Binding was decreased to 63 % of control and the extent of inhibition was maximal at 100 µg\ml monoclonal antibody. An irrelevant monoclonal antibody against bovine liver PDI had no effect on the binding of "#&I-PDGF BB to its receptor. We used α # -macroglobulin, a known PDGF BBbinding protein that prevents PDGF BB from interacting with its receptor [36] , as an internal control for these experiments. α # -Macroglobulin inhibited PDGF BB binding to its receptor on rat SMCs with half-maximal effect at 140 nM, which is similar to the value (approx. 100 nM) reported by Raines et al. [36] (results not shown).
We expected that binding of TSP1 to PDGF BB would influence interaction of PDGF BB with its receptor on rat SMCs. Ca# + -replete TSP1 non-competitively inhibited the binding of PDGF BB to its receptor ( Figure 5 ). The data of Figures 5(a) and 5(b) were fitted to the non-competitive inhibition binding model shown in Scheme 1 and described by eqn. (5) . The data in Figure 5 (b) were fitted by using fixed values of K R (9 pM) and [R] ! (7 pM) (see above), with the dissociation constant for interaction of "#&I-PDGF BB with TSP1 (K H ) and α as the unknown parameters. The best-fit values were K H l 2p2 nM and α l 5p2. This value for K H is comparable with the value determined for the interaction of the purified proteins, 32p5 nM (Table 1) .
Data from Figure 5 (a) in the presence of TSP1 were fitted by using fixed values of K R (11 pM) and [R] ! (7 pM) and assuming α l 5 (from Figure 5b) , with K H as the unknown parameter. The best-fit value was K H l 15p5 nM, which is comparable with the estimate of this parameter from the results of Figure 5 (b) (2p2 nM) and the value determined from competitive binding assays with purified proteins (32p5 nM ; Table 1 ). The general agreement in estimates of the fitted parameters from the results of Figures 2 and 5 validate the non-competitive inhibition model proposed to account for the data. However, it should be emphasized that this is the simplest binding model that accounted for the data. Other, more complicated, binding models could also be envisaged that are not excluded by our results.
DISCUSSION
TSP1 has been shown to play an important role in PDGFmediated proliferation and migration of cultured SMCs [23, 24] . The mechanism by which TSP1 promotes PDGF activity is not understood but it is apparent that TSP1 must interact with the SMC surface to be active. We hypothesized that binding of PDGF to TSP1 on the SMC surface might be a means by which TSP1 enhances PDGF function. We now report that PDGF BB bound tightly and specifically to TSP1 and that this interaction was markedly dependent on the disulphide bond conformation of TSP1. Also, binding of PDGF BB to TSP1 did not preclude PDGF BB from binding to its receptor on rat aortic SMCs.
TSP1 functions in i o bound to cell surfaces or to extracellular matrix, and there is evidence that the conformation of TSP1 bound to cells or matrix resembles that of the form used in these studies, that is TSP1 purified in buffers containing 0n1 mM Ca# + . We have shown that the anti-TSP1 monoclonal antibodies D4n6 and A65M interact with this form of TSP1 bound to plastic or extracellular matrix, but not with TSP1 purified in buffers containing 2 mM Ca# + [39] . Antibody D4n6 immunostained TSP1 in the extracellular matrix and on the surface of cultured fibroblasts and SMCs [40] (L. J. Matthias and P. J. Hogg, unpublished work), and antibodies D4n6 and A65M immunostained blood vessel walls and occasional matrix cells in human rheumatoid synovial tissue [39] . Moreover, antibody A65M was developed against TSP1 in endothelial cell extracellular matrix [41] , implying that the form of TSP1 used in these studies is produced by endothelial cells. Importantly, Majack et al. [23] showed that antibodies (D4n6 and A6n1) specific for TSP1 purified in 0n1 mM Ca# + -containing buffers are effective in inhibiting PDGF-mediated SMC proliferation.
The observation that cell-surface TSP1 is essential for rat aortic SMC proliferation [23] suggested that the binding of PDGF BB to TSP1 on the surface of SMC might participate in the interaction of PDGF BB with its receptor. We have shown that anti-TSP1 monoclonal antibodies partly inhibited the binding of labelled PDGF BB to its receptor on rat SMCs, and added TSP1 non-competitively inhibited the binding of labelled PDGF BB to rat SMCs. In other words, PDGF BB -TSP1 complexes bound to PDGF receptor but with 1\(5p2) times the affinity shown by uncomplexed PDGF BB . This non-competitive inhibition by TSP1 is in contrast with other PDGF-binding proteins, α # -macroglobulin [36] and SPARC [42] , which competitively inhibit the binding of PDGF to its receptor.
An important question is what consequences does binding of PDGF BB to TSP1 have for the activity of PDGF BB ? There are similarities between the PDGF BB -TSP1-PDGF receptor interactions described herein and the fibroblast growth factor (FGF)-glycosaminoglycan-FGF receptor interactions [43] . Cellsurface glycosaminoglycans have been shown to enhance the binding or targeting of FGF to its signalling receptor, probably by decreasing the dimensionality of FGF diffusion from three dimensions in the extracellular space to two dimensions at the cell surface [43] . When restricted to diffusion in two dimensions on the cell surface, FGF is more likely to encounter and bind to its less abundant high-affinity signalling receptors. The net effect is an increase in the local concentration of FGF at the cell surface, which greatly enhances chances of interaction with highaffinity FGF receptors. TSP1 produced by SMCs binds to the SMC surface and extracellular matrix [11, 23] . It is plausible that PDGF BB -TSP1 interactions result in high local concentrations of PDGF BB in the vicinity of or at the cell surface, which will enhance the interaction of PDGF BB with its signalling receptors. Another similarity between the FGF-glycosaminoglycan and PDGF BB -TSP1 interactions is their ionic nature (Figure 3) , which usually implies rapid dissociation rates. In contrast, highaffinity signalling receptors such as the FGF and PDGF receptors are often characterized by rapid on-rates and slow off-rates [33, 43] .
The binding of PDGF BB to TSP1 was initially an unexpected observation as two other investigators had reported that PDGF BB and TSP1 do not interact. Raines et al. [42] reported that radiolabelled PDGF BB did not interact with TSP1 bound to nitrocellulose, and Yabkowitz et al. [24] reported that radiolabelled PDGF BB did not co-immunoprecipitate with PDGF. A possible explanation for these seemingly conflicting observations is the finding that PDGF BB does not bind to Ca# + -replete TSP1 purified in buffers containing 2 mM Ca# + (P. J. Hogg, unpublished work). Yabkowitz et al. [24] used this non-binding form of TSP1 in their studies, which might account for their negative result. Raines et al. [42] did not indicate their source of TSP1 so this comparison cannot be made. Therefore the findings reported herein and those of Raines et al. [42] and Yabkowitz et al. [24] are not necessarily contradictory. These results highlight the structural lability of TSP1 and the necessity to consider this when studying the functions of this protein.
Disulphide isomerization in TSP1 might be a means by which certain functions of TSP1 are regulated [12, 29, 39, [44] [45] [46] . We have shown that PDI catalyses disulphide interchange in TSP1 that markedly changes the affinity of binding of cathepsin G and anti-TSP1 monoclonal antibodies [29, 39] and PDGF BB (Figure 4 ) to TSP1. PDI was recently demonstrated on the platelet surface [47, 48] and we have found that PDI is present on the surface of rat aortic SMCs in an ' active ' reduced conformation (L. J. Matthias and P. J. Hogg, unpublished work). It is therefore plausible that catalysis of disulphide interchange in TSP1 by cellsurface PDI might be a mechanism that controls the binding of PDGF BB to TSP1.
In conclusion, the findings herein imply that binding of PDGF BB to TSP1 might assist in the targeting of PDGF BB to its receptor on SMCs, which might explain why cell-surface TSP1 is important for PDGF-mediated proliferation and migration of vascular SMCs. Binding of PDGF BB to TSP1 might have other consequences, such as protecting PDGF BB from proteolytic inactivation. Further understanding of this system will be aided by determining the binding site on TSP1 and PDGF BB and vice versa, as specific perturbation of the PDGF BB -TSP1 interaction would help to elucidate the significance of this interaction of PDGF BB function.
